Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-iminoribitol
2. Bcx-1777
3. Bcx1777
4. Forodesine
5. Immh Cpd
6. Immucillin H
7. Immucillin-h
1. 284490-13-7
2. Forodesine Hcl
3. Forodesine (hydrochloride)
4. Bcx-1777
5. Bcx-1777 Hydrochloride
6. 6sn82y9u73
7. (-)-7-((2s,3s,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl)-1,5-dihydro-4h-pyrrolo(3,2-d)pyrimidin-4-one Monohydrochloride
8. 4h-pyrrolo(3,2-d)pyrimidin-4-one, 7-((2s,3s,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl)-1,5-dihydro-, Monohydrochloride
9. 7-[(2s,3s,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,5-dihydropyrrolo[3,2-d]pyrimidin-4-one;hydrochloride
10. Immucillin-h Hydrochloride
11. Unii-6sn82y9u73
12. Forodesine Hydrochloride [usan]
13. Forodesine Hydrochloride [usan:jan]
14. Forodesinehydrochloride
15. Chembl550755
16. Schembl1949526
17. Schembl15525350
18. Dtxsid90182647
19. Forodesine Hydrochloride (jan/usan)
20. Forodesine Hydrochloride [mi]
21. Forodesine Hydrochloride [jan]
22. Cs-3780
23. Forodesine Hydrochloride [mart.]
24. Forodesine Hydrochloride [who-dd]
25. Hy-16209
26. D04245
27. Q27265452
28. 7-((2s,3s,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl)-3h-pyrrolo[3,2-d]pyrimidin-4-(5h)-one Hydrochloride
29. 7-[(2s,3s,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one;hydrochloride
Molecular Weight | 302.71 g/mol |
---|---|
Molecular Formula | C11H15ClN4O4 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 2 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 130 |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 404 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Treatment of Cutaneous T-Cell Lymphoma
Market Place
ABOUT THIS PAGE
72
PharmaCompass offers a list of 284490-13-7 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 284490-13-7 manufacturer or 284490-13-7 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 284490-13-7 manufacturer or 284490-13-7 supplier.
PharmaCompass also assists you with knowing the 284490-13-7 API Price utilized in the formulation of products. 284490-13-7 API Price is not always fixed or binding as the 284490-13-7 Price is obtained through a variety of data sources. The 284490-13-7 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A FORODESINE HYDROCHLORIDE [MI] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of FORODESINE HYDROCHLORIDE [MI], including repackagers and relabelers. The FDA regulates FORODESINE HYDROCHLORIDE [MI] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. FORODESINE HYDROCHLORIDE [MI] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A FORODESINE HYDROCHLORIDE [MI] supplier is an individual or a company that provides FORODESINE HYDROCHLORIDE [MI] active pharmaceutical ingredient (API) or FORODESINE HYDROCHLORIDE [MI] finished formulations upon request. The FORODESINE HYDROCHLORIDE [MI] suppliers may include FORODESINE HYDROCHLORIDE [MI] API manufacturers, exporters, distributors and traders.
FORODESINE HYDROCHLORIDE [MI] Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of FORODESINE HYDROCHLORIDE [MI] GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right FORODESINE HYDROCHLORIDE [MI] GMP manufacturer or FORODESINE HYDROCHLORIDE [MI] GMP API supplier for your needs.
A FORODESINE HYDROCHLORIDE [MI] CoA (Certificate of Analysis) is a formal document that attests to FORODESINE HYDROCHLORIDE [MI]'s compliance with FORODESINE HYDROCHLORIDE [MI] specifications and serves as a tool for batch-level quality control.
FORODESINE HYDROCHLORIDE [MI] CoA mostly includes findings from lab analyses of a specific batch. For each FORODESINE HYDROCHLORIDE [MI] CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
FORODESINE HYDROCHLORIDE [MI] may be tested according to a variety of international standards, such as European Pharmacopoeia (FORODESINE HYDROCHLORIDE [MI] EP), FORODESINE HYDROCHLORIDE [MI] JP (Japanese Pharmacopeia) and the US Pharmacopoeia (FORODESINE HYDROCHLORIDE [MI] USP).